Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and...
Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients
About this item
Full title
Author / Creator
Song, Shuaiwei , Cai, Xintian , Hu, Junli , Zhu, Qing , Shen, Di , Ma, Huimin , Zhang, Yingying , Ma, Rui , Yang, Wenbo , Hong, Jing , Zhang, Delian and Li, Nanfang
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
While the role of aldosterone in bone metabolism is well established, the specific effects of the widely used aldosterone antagonist, spironolactone, on bone health are not fully understood. This study aimed to investigate the effects of spironolactone on osteoporosis and future fracture risk in middle-aged and elderly hypertensive patients, reveal...
Alternative Titles
Full title
Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2e7a79edbab846e28c8f897a72d05994
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e7a79edbab846e28c8f897a72d05994
Other Identifiers
ISSN
1177-8881
E-ISSN
1177-8881
DOI
10.2147/DDDT.S466904
